Lasca

Medicinal product

(Invented) name

Lasca

Active substance (s)

Dienogestas/Etinilestradiolis

Strength

2 mg/0,03 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03AA16, Dienogest and ethinylestradiol

Marketing authorisation holder

UAB Exeltis Baltics, Lietuva

Date of authorisation

2014-05-14

Date of renewal

2018-12-14

Documents

3560 Pakuotės lapelis 2024 12 15.docx

Mokomoji medziaga sveikatos prieziuros specialistams (kontrolinis sarasas).pdf

Paciento kortele.pdf

3560 Lasca RPP 2024 12 15.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/3559/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Dienogestas	2 mg
Etinilestradiolis	0,03 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
50865	64755	1064755	lizdinė plokštelė	N21		Receptinis	LT/1/14/3560/001	Tiekiama	-	-	No	-	-	Download
59164	73387	1073387	lizdinė plokštelė	N3x21		Receptinis	LT/1/14/3560/002	Netiekiama	-	-	No	-	-
59165	73388	1073388	lizdinė plokštelė	N6x21		Receptinis	LT/1/14/3560/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-12-14	Perregistruotas
2014-05-14	Registruotas